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five classic articles in somatic cell 
reprogramming
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New Haven, Connecticut
research on somatic cell reprogramming has progressed significantly over the past few
decades, from nuclear transfer into frogs’ eggs in 1952 to the derivation of human-induced
pluripotent stem (iPS†) cells in the present day. In this article, I review five landmark papers
that have laid the foundation for current efforts to apply somatic cell reprogramming in the
clinic.
Recently, ectopic expression of four
transcription factors (Oct4, Sox2, Klf4, c-
Myc)  was  shown  to  reprogram  somatic
cells into induced pluripotent stem (iPS)
cells, which have similar characteristics as
embryonic stem (ES) cells [1]: self-renewal
and pluripotency. Successful reprogram-
ming has excited the biomedical commu-
nity because iPS cells have unprecedented
potential in personalized cell-based therapy
as well as in in vitro disease models. After
reviewing the literature, I selected the five
most important articles in the field of so-
matic cell reprogramming. Although there
have been many excellent research articles
published since the first demonstration of
direct reprogramming of murine somatic
cells [1], I have chosen reports that paved
the way to these recent successes.
Briggs r, King TJ. Transplan-
TaTion of living nuclei from
BlasTula cells inTo enucle-
aTed frogs’ eggs. proc naTl
acad sci usa. 1952;38(5):455-63
In this classic paper, Briggs and King
showed that nuclei from Rana pipiens(North-
ern Leopard Frog) blastula cells undergo nor-
mal  cleavage  and  develop  into  complete
embryos  when  transplanted  into  enclosed
oocytes [2]. Gurdon and colleagues elaborated
on this finding, reporting that even fully dif-
ferentiated intestinal cells from Xenopuscould
be reprogrammed by frog oocytes [3]. Al-
though the efficiency of reprogramming was
very low, these results demonstrated the im-
portant concept of cellular reprogramming by
pluripotency-inducing factors in oocytes.
To whom all correspondence should be addressed: In-Hyun Park, PhD, Assistant Profes-
sor of Genetics, Department of Genetics, Yale Stem Cell Center, Yale University School of
Medicine, 10 Amistad 201B, New Haven, CT 06520; E-mail: inhyun.park@yale.edu.
†Abbreviations: iPS, induced pluripotent stem; ES, embryonic stem; EC, embryonic carci-
noma; SCNT, somatic cell nuclear transfer.evans mJ, Kaufman mH. 
esTaBlisHmenT in culTure of
pluripoTenTial cells from
mouse emBryos. naTure.
1981;292(5819):154-6
After noting spontaneous formation of
testicular teratoma in the 129 mouse strain
[4], Evans and Kaufman isolated embryonic
carcinoma (EC) cells [5] and examined them
for the basic characteristics of stem cells:
pluripotency and self-renewing ability [6].
Based on this research, the authors, together
with Martin, succeeded in isolating embry-
onic stem (ES) cells from normally devel-
oping mouse blastocysts [7]. This result not
only facilitated future studies of mouse ge-
netics, but also initiated the in vitro culturing
of iPS cells.
WilmuT i, scHnieKe ae, mcWHir
J, Kind aJ, campBell KH. viaBle
offspring derived from feTal
and adulT mammalian cells.
naTure. 1997;385(6619):810-3
After Briggs and King demonstrated the
cell fate change using frog oocytes [2], so-
matic cell nuclear transfer (SCNT) was not
successful in other species until 1997, when
the sheep Dolly was cloned by Dr. Wilmut
[8]. In this pioneering paper, completely dif-
ferentiated mammalian somatic cells were
shown to become pluripotent after nuclear
transfer into oocytes, giving rise to viable
animals  and  allowing  in-depth  study  of
mammalian cell fate change [9].
THomson Ja, eT al. emBryonic
sTem cell lines derived from
Human BlasTocysTs. science.
1998;282(5391):1145-7 
After mouse ES cells were first isolated,
nonhuman primate ES cells were derived and
used to study primate tissue differentiation in
vitro[10]. However, this 1998 report demon-
strated  the  first  successful  derivation  of
human ES cells [11]. These human ES cells
provided the opportunity to study human em-
bryonic development and develop cell-based
therapies for clinical use, as well as estab-
lishing a platform for the derivation of human
iPS cells.
TaKaHasHi K, TanaBe K, oHnuKi
m, nariTa m, icHisaKa T, Tomoda
K, eT al. inducTion of pluripo-
TenT sTem cells from adulT
Human fiBroBlasTs By defined
facTors. cell. 2007;131(5):861-72
This landmark paper provided the first
demonstration of direct reprogramming of
mammalian cells using defined factors. Here,
Takahashi and Yamanaka combined previous
knowledge of murine ES cell cultures, the
concept of pluripotency, and the plasticity of
the mammalian genome to convert differen-
tiated cellular fate to pluripotency by artifi-
cial  overexpression  of  a  set  of  genes.
Specifically, they transduced Fbx15 reporter
mouse fibroblasts with 24 candidate repro-
gramming genes [1]. Fbx15 is only expressed
in pluripotent stem cells, and so activation of
Fbx15 in transduced cells indicated success-
ful reprogramming. Remarkably, the intro-
duction  of  only  four  transcription  factors
(Oct4, Sox2, Klf4, c-Myc) was sufficient to
give rise to pluripotent cells, termed “induced
pluripotent stem cells.”
Following Yamanaka’s original report
on the derivation of murine iPS cells, suc-
cessful generation of human iPS cells was
reported by three independent groups that
used a similar approach to express human
versions of the four reprogramming factors
in different combinations (OCT4, SOX2,
NANOG, LIN28) [12-14]. Since then, there
has been a ceaseless effort to 1) derive ther-
apeutically safe iPS cells; 2) investigate the
molecular mechanism of reprogramming; 3)
improve reprogramming efficiency; and 4)
establish an in vitro human disease model
using iPS cells [15]. Additionally, because
the ultimate use of iPS cells lies in cell-re-
placement therapy, direct transdifferentia-
tion  into  cells  has  been  attracting  more
attention lately [16]. Thanks to the founda-
tional  work  of  previous  developmental,
medical, and basic scientists, the direct re-
programming of cell fate change is possible
and is making more exciting findings in
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treatment of patients using autologous iPS
cells, possible.
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